FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: If approved, this new vaccine could impact public health initiatives and vaccine distribution efforts across New Jersey, potentially offering an additional option for flu prevention for residents.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.